Product News
Neurolentech Signs Technology Access Partnership With Kaerus Bioscience To Advance Neurodevelopmental Disorder Research
Kaerus Bioscience will access Neurolentech’s NDD Drug Discovery Platform to support development of its preclinical asset pipeline for numerous genetic syndromes.
Product News
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) has announced the grand opening of its new cGMP mRNA manufacturing facility.
Product News
ELRIG UK and SRG Announce Partnership To Advance Life Science Professionals in Drug Discovery
Partnership endorses mission to facilitate career progression and support life science industry growth.
Product News
Revolutionising Nanoparticle Production: Technical Evaluation Introduces Cutting-Edge Formulation Technology
In a significant stride towards advancing nanoparticle drug delivery manufacturing technology, German pharmatech company, leon-nanodrugs GmbH (LEON), proudly announces a pioneering technical evaluation by CMAC, University of Strathclyde.
Product News
Metrion Biosciences Enhances High Throughput Screening Services With Access to Enamine Compound Libraries
Access to compound collection enables greater flexibility and efficiencies in screening and target identification.
Product News
University of Liverpool To Use Touchlight’s Rapid Enzymatic dbDNA in Fully Personalised Neoantigen Cancer Vaccine Clinical
The UK’s Medical Research Council is funding a 10-patient Phase I study to deliver rapid personalised treatment for lung cancer patients.
Product News
Therapeutic Potential of CD20 X CD3 Bispecific Antibodies
As of March 2024, the FDA has approved three CD20 × CD3 BsAbs: mosunetuzumab (Lunsumio) for relapsed or refractory follicular lymphoma (R/R FL), glofitamab (Columvi) for relapsed or refractory diffuse B cell lymphoma
Product News
Sino Biological Announces Services Partnership With Rapid Novor
Sino Biological and Rapid Novor partner to offer combined antibody development and sequencing services.
Product News
InSphero and PharmaNest Unveil a Promising Tool for MASH Drug Discovery
InSphero's Liver Disease team has published a groundbreaking peer-reviewed paper in Nature's Scientific Reports, challenging the limitations of in vitro models in MASH Drug Discovery.
Product News
ProBioGen Partners With MAPP BIOPHARMACEUTICAL, INC. for Groundbreaking Development of Afucosylated Antibody Against Marburg Virus Disease
ProBioGen, is pleased to announce the execution of services and license agreements with MAPP BIOPHARMACEUTICAL, INC. to develop a cell line for an afucosylated antibody targeting Marburg virus (MARV) infection.
Advertisement
